DALLAS--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global technology and specialty materials company, today reported third quarter 2017 GAAP diluted earnings per share of $1.68, second-highest for a third quarter, and adjusted earnings per share of $1.93, an all-time record. Net sales expanded 18 percent year over year to $1.6 billion. A combination of commercial execution in the Acetyl Chain, extension of the pipeline model in Materials Solutions, and broad productivity gains more than offset the expected declines in tow earnings to deliver robust results. The Acetyl Chain grew profitability by exercising the optionality in its commercial model to overcome the disruption from Hurricane Harvey. Advanced Engineered Materials (AEM) grew project commercializations across regions in both legacy and acquired polymers.
Third Quarter 2017 Financial Highlights:
|
Three Months Ended |
||||||||
| 2017 | 2016 | |||||||
| (unaudited) | ||||||||
| (In $ millions) | ||||||||
| Operating Profit (Loss) | ||||||||
| Advanced Engineered Materials | 97 | 93 | ||||||
| Consumer Specialties | 53 | 68 | ||||||
| Total Materials Solutions | 150 | 161 | ||||||
| Industrial Specialties | 20 | 25 | ||||||
| Acetyl Intermediates | 128 | 83 | ||||||
| Eliminations | — | — | ||||||
| Total Acetyl Chain | 148 | 108 | ||||||
| Other Activities | (46 | ) | (23 | ) | ||||
| Total | 252 | 246 | ||||||
|
Three Months Ended September 30, |
||||||||||
| 2017 | 2016 | |||||||||
| (unaudited) | ||||||||||
| (In $ millions, except per share data) | ||||||||||
| Net Earnings (Loss) | 228 | 263 | ||||||||
| Adjusted EBIT(1)(2) | ||||||||||
| Advanced Engineered Materials | 147 | 127 | ||||||||
| Consumer Specialties | 79 | 98 | ||||||||
| Total Materials Solutions | 226 | 225 | ||||||||
| Industrial Specialties | 23 | 25 | ||||||||
| Acetyl Intermediates | 134 | 84 | ||||||||
| Eliminations | — | — | ||||||||
| Total Acetyl Chain | 157 | 109 | ||||||||
| Other Activities | (38 | ) | (15 | ) | ||||||
| Total | 345 | 319 | ||||||||
| Equity Earnings, Cost-Dividend Income, Other Income (Expense) | ||||||||||
| Advanced Engineered Materials | 45 | 33 | ||||||||
| Consumer Specialties | 26 | 27 | ||||||||
| Total Materials Solutions | 71 | 60 | ||||||||
| Operating EBITDA(1) | 423 | 390 | ||||||||
| Diluted EPS - continuing operations | $ | 1.68 | $ | 1.83 | ||||||
| Diluted EPS - total | $ | 1.65 | $ | 1.81 | ||||||
| Adjusted EPS(1) | $ | 1.93 | $ | 1.67 | ||||||
| Net cash provided by (used in) investing activities | (68 | ) | (54 | ) | ||||||
| Net cash provided by (used in) financing activities | (247 | ) | 265 | |||||||
| Net cash provided by (used in) operating activities | 255 | 304 | ||||||||
| Free cash flow(1) | 181 | 237 | ||||||||
| ______________________________ | ||
|
(1) |
See "Non-US GAAP Financial Measures" below. | |
|
(2) |
The Company's discussion of adjusted earnings includes use of terms such as "segment income" and "core income." Those non-GAAP terms are defined below and reconciled in our Non-US GAAP Financial Measures and Supplemental Information document referenced below. |
|
Third Quarter 2017 Highlights:
- Completed de-bottlenecking projects over the last year that increased output by 10 percent per unit for select POM, UHMW-PE, PPS and PBT assets in the US, Germany, and China.
- Announced plans to add production lines in the US, Italy and China to expand compounding capacity by roughly 100 kt per year. The expansion will be completed in 2018-2019 and will support demand growth across end-market applications.
- Commercialized a record 585 projects in the third quarter of 2017, a 67 percent increase from third quarter of 2016, in engineered materials (AEM excluding affiliates). Increased target for projects closed in 2017 to above 2,100, up 52 percent from 2016.
- Completed the SAP system integration of Nilit Plastics, a major milestone towards full integration into Celanese.
- Advanced on the previously announced 150 kt expansion of vinyl acetate monomer at the Clear Lake, Texas facility. This expansion, expected to be commissioned at the end of 2018, will raise plant capacity to 450 kt making it the largest VAM plant in the western hemisphere.
- Filed for regulatory approval of the tow joint venture with Blackstone in all six jurisdictions and received approval in Mexico. The European Commission is expected to continue its assessment with a final decision expected in spring 2018.
Third Quarter 2017 Business Segment Overview
Materials Solutions
Materials Solutions reported record net sales of $730 million in the third quarter, a 24 percent increase year over year driven by growth in Advanced Engineered Materials that outpaced the decline in Consumer Specialties. AEM delivered its highest ever third quarter GAAP operating profit of $97 million and highest ever segment income of $147 million. There is strong receptivity for Celanese's customer-centric approach coupled with the breadth of polymer solutions which continues to strengthen AEM's growth profile. The segment set a new watermark of advancing 585 projects to commercialization in the quarter by expanding the opportunity set and improving its win-rate. Volume in the third quarter of 2017 grew over last year mainly from the Nilit and SO.F.TER. acquisitions, growth in Asia and new projects. As expected, the addition of the Nilit and SO.F.TER. acquisitions along with higher indirect costs from Hurricane Harvey lowered GAAP operating profit margin and segment income margin year over year. Both acquisitions were segment income accretive in the quarter and their margin is expected to improve over the next few years as synergies are realized.
Acetate tow volume and price in the third quarter declined compared to the same quarter in 2016 due to lower tow industry capacity utilization rates and offset improvements in productivity. Results were consistent sequentially.
Affiliate earnings in Materials Solutions increased 18 percent year over year to $71 million mainly due to the impact of the Ibn Sina turnaround in the third quarter of 2016 which did not repeat in 2017.
Acetyl Chain
The Acetyl Chain GAAP operating profit of $148 million in the third quarter was $40 million higher than the third quarter of 2016 while core income of $157 million was $48 million higher. Profitability grew despite operational and supply chain disruptions in the Gulf Coast caused by Hurricane Harvey. The chain responded by swiftly executing contingency plans to minimize impact and quickly restore operations. Pricing was higher than the third quarter of last year driven by the success of commercial actions mainly in Asia as well as continued strength in global acetyls. Margin expansion in the chain was driven by the Acetyl Intermediates segment which recorded GAAP operating margin of 18.7 percent and segment income margin of 19.6 percent, both all time records. Results in the quarter highlight the chain's business model which leverages volatility in the global acetyl supply chain to maximize profitability.
Cash Flow
Operating cash flow in the third quarter was $255 million and free cash flow was $181 million. Capital expenditures were $64 million in the quarter. The company repurchased approximately 2 million shares for $200 million in the quarter and $500 million total for the year. $262 million of cash was returned to shareholders in the quarter including $62 million in dividends.
Outlook
"Success in the third quarter and for most of 2017 has come from our ability to rapidly translate changes in the business environment into new value creation opportunities through our business models. In Advanced Engineered Materials, the disciplined approach to innovation through the pipeline model has raised profits and provided a road map for accelerating value uplift from the SO.F.TER. and Nilit acquisitions. The Acetyl Chain is expected to maintain its commercial traction in the quarter and additional initiatives are in place to take advantage of the gradual strengthening of the market. There is business and productivity momentum that should offset fourth quarter weakness. This combination gives confidence we can grow 2017 adjusted earnings per share toward the higher end of the 9-11 percent range, year over year," said Mark Rohr, chairman and chief executive officer.
We are unable to reconcile forecasted adjusted earnings per share growth to US GAAP diluted earnings per share without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, is not practical.
The Company's earnings presentation and prepared remarks related to the third quarter results will be posted on its website at www.celanese.com under Investor Relations/Events and Presentations after market close on October 16, 2017. Information about Non-US GAAP measures is included in a Non-US GAAP Financial Measures and Supplemental Information document posted on the website and available at the link below. See "Non-GAAP Financial Measures" below.
Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our two complementary business cores, Acetyl Chain and Materials Solutions, use the full breadth of Celanese's global chemistry, technology and business expertise to create value for our customers and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,500 employees worldwide and had 2016 net sales of $5.4 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.
Forward-Looking Statements
This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, synergies, performance, capital expenditures, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions, including the announced joint venture transaction. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release, including with respect to the joint venture. These risks and uncertainties include, among other things: changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; the ability to maintain plant utilization rates and to implement planned capacity additions and expansions; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; the ability to identify desirable potential acquisition targets and to consummate acquisition or investment transactions consistent with the Company's strategy; increased price competition and the introduction of competing products by other companies; market acceptance of our technology; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war or terrorist incidents or as a result of weather or natural disasters; potential liability for remedial actions and increased costs under existing or future environmental regulations, including those relating to climate change; potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Non-GAAP Financial Measures
Presentation
This document presents the Company's business segments in two subtotals, reflecting our two cores, the Acetyl Chain and Materials Solutions, based on similarities among customers, business models and technical processes. As described in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q, the Acetyl Chain includes the Company's Acetyl Intermediates segment and the Industrial Specialties segment. Materials Solutions includes the Company's Advanced Engineered Materials segment and the Consumer Specialties segment.
Use of Non-US GAAP Financial Information
This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, adjusted earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin is operating margin; for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; and for free cash flow is net cash provided by (used in) operations.
Definitions of Non-US GAAP Financial Measures
- Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8 of our Non-US GAAP Financial Measures and Supplemental Information document). We may provide guidance on adjusted EBIT but are unable to reconcile forecasted adjusted EBIT to a US GAAP financial measure without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains and losses, which may be significant, is not practical. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales.
- Adjusted EBIT by core (i.e., Acetyl Chain and/or Materials Solutions) may also be referred to by management as core income. Adjusted EBIT margin by core may also be referred to by management as core income margin. Adjusted EBIT by business segment may also be referred to by management as segment income. Adjusted EBIT margin by business segment may also be referred to by management as segment income margin.
- Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization.
-
Adjusted earnings per share is a performance measure used by the
Company and is defined by the Company as earnings (loss) from
continuing operations attributable to Celanese Corporation, adjusted
for income tax (provision) benefit, Certain Items, and refinancing and
related expenses, divided by the number of basic common shares and
dilutive restricted stock units and stock options calculated using the
treasury method. We may provide guidance on adjusted earnings per
share but are unable to reconcile forecasted adjusted earnings per
share to a US GAAP financial measure without unreasonable efforts
because a forecast of Certain Items, such as mark-to-market pension
gains and losses, which may be significant, is not practical.
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a of our Non-US GAAP Financial Measures and Supplemental Information document summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results. - Free cash flow is a liquidity measure used by the Company and is defined by the Company as cash flow from operations, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our methanol joint venture, Fairway Methanol LLC ("Fairway").
Reconciliation of Non-US GAAP Financial Measures
Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure, together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the SEC on or about October 16, 2017 and also available on our website at www.celanese.com under Financial Information, Non-GAAP Financial Measures, or at this link: http://investors.celanese.com/interactive/lookandfeel/4103411/Non-GAAP.PDF.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
Supplemental Information
Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and Supplemental Information document.
|
Consolidated Statements of Operations - Unaudited |
||||||||
|
Three Months Ended September 30, |
||||||||
| 2017 | 2016 | |||||||
| (In $ millions, except share and per share data) | ||||||||
| Net sales | 1,566 | 1,323 | ||||||
| Cost of sales | (1,181 | ) | (968 | ) | ||||
| Gross profit | 385 | 355 | ||||||
| Selling, general and administrative expenses | (112 | ) | (81 | ) | ||||
| Amortization of intangible assets | (5 | ) | (3 | ) | ||||
| Research and development expenses | (19 | ) | (20 | ) | ||||
| Other (charges) gains, net | — | (3 | ) | |||||
| Foreign exchange gain (loss), net | 4 | (1 | ) | |||||
|
Gain (loss) on disposition of businesses and assets, net |
(1 | ) | (1 | ) | ||||
| Operating profit (loss) | 252 | 246 | ||||||
| Equity in net earnings (loss) of affiliates | 50 | 41 | ||||||
| Interest expense | (32 | ) | (28 | ) | ||||
| Refinancing expense | — | (4 | ) | |||||
| Interest income | 1 | — | ||||||
| Dividend income - cost investments | 24 | 26 | ||||||
| Other income (expense), net | (6 | ) | — | |||||
| Earnings (loss) from continuing operations before tax | 289 | 281 | ||||||
| Income tax (provision) benefit | (57 | ) | (15 | ) | ||||
| Earnings (loss) from continuing operations | 232 | 266 | ||||||
| Earnings (loss) from operation of discontinued operations | (5 | ) | (4 | ) | ||||
| Income tax (provision) benefit from discontinued operations | 1 | 1 | ||||||
| Earnings (loss) from discontinued operations | (4 | ) | (3 | ) | ||||
| Net earnings (loss) | 228 | 263 | ||||||
| Net (earnings) loss attributable to noncontrolling interests | (2 | ) | (1 | ) | ||||
| Net earnings (loss) attributable to Celanese Corporation | 226 | 262 | ||||||
| Amounts attributable to Celanese Corporation | ||||||||
| Earnings (loss) from continuing operations | 230 | 265 | ||||||
| Earnings (loss) from discontinued operations | (4 | ) | (3 | ) | ||||
| Net earnings (loss) | 226 | 262 | ||||||
| Earnings (loss) per common share - basic | ||||||||
| Continuing operations | 1.68 | 1.84 | ||||||
| Discontinued operations | (0.03 | ) | (0.02 | ) | ||||
| Net earnings (loss) - basic | 1.65 | 1.82 | ||||||
| Earnings (loss) per common share - diluted | ||||||||
| Continuing operations | 1.68 | 1.83 | ||||||
| Discontinued operations | (0.03 | ) | (0.02 | ) | ||||
| Net earnings (loss) - diluted | 1.65 | 1.81 | ||||||
| Weighted average shares (in millions) | ||||||||
| Basic | 136.6 | 144.0 | ||||||
| Diluted | 137.0 | 144.6 | ||||||
|
Consolidated Balance Sheets - Unaudited |
||||||||
|
As of |
As of |
|||||||
| (In $ millions) | ||||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | 461 | 638 | ||||||
| Trade receivables - third party and affiliates, net | 989 | 801 | ||||||
| Non-trade receivables, net | 260 | 223 | ||||||
| Inventories | 809 | 720 | ||||||
| Marketable securities, at fair value | 31 | 30 | ||||||
| Other assets | 63 | 60 | ||||||
| Total current assets | 2,613 | 2,472 | ||||||
| Investments in affiliates | 938 | 852 | ||||||
| Property, plant and equipment, net | 3,706 | 3,577 | ||||||
| Deferred income taxes | 201 | 159 | ||||||
| Other assets | 306 | 307 | ||||||
| Goodwill | 995 | 796 | ||||||
| Intangible assets, net | 303 | 194 | ||||||
| Total assets | 9,062 | 8,357 | ||||||
| LIABILITIES AND EQUITY | ||||||||
| Current Liabilities | ||||||||
| Short-term borrowings and current installments of long-term debt - third party and affiliates | 435 | 118 | ||||||
| Trade payables - third party and affiliates | 695 | 625 | ||||||
| Other liabilities | 343 | 322 | ||||||
| Income taxes payable | 77 | 12 | ||||||
| Total current liabilities | 1,550 | 1,077 | ||||||
| Long-term debt, net of unamortized deferred financing costs | 2,954 | 2,890 | ||||||
| Deferred income taxes | 195 | 130 | ||||||
| Uncertain tax positions | 153 | 131 | ||||||
| Benefit obligations | 845 | 893 | ||||||
| Other liabilities | 230 | 215 | ||||||
| Commitments and Contingencies | ||||||||
| Stockholders' Equity | ||||||||
| Preferred stock | — | — | ||||||
| Common stock | — | — | ||||||
| Treasury stock, at cost | (2,031 | ) | (1,531 | ) | ||||
| Additional paid-in capital | 171 | 157 | ||||||
| Retained earnings | 4,781 | 4,320 | ||||||
| Accumulated other comprehensive income (loss), net | (206 | ) | (358 | ) | ||||
| Total Celanese Corporation stockholders' equity | 2,715 | 2,588 | ||||||
| Noncontrolling interests | 420 | 433 | ||||||
| Total equity | 3,135 | 3,021 | ||||||
| Total liabilities and equity | 9,062 | 8,357 | ||||||
Non-US GAAP Financial Measures and Supplemental Information
October 16, 2017
In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.
Purpose
The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures. This document is updated quarterly.
Presentation
This document presents the Company's business segments in two subtotals, reflecting our two cores, the Acetyl Chain and Materials Solutions, based on similarities among customers, business models and technical processes. As described in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q, the Acetyl Chain includes the Company's Acetyl Intermediates segment and the Industrial Specialties segment. Materials Solutions includes the Company's Advanced Engineered Materials segment and the Consumer Specialties segment.
Use of Non-US GAAP Financial Measures
From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.
Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Investor Relations/Financial Information/SEC Filings page of our website, www.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.
Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Investor Relations/Financial Information/Non-GAAP Financial Measures page of our website, www.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.
This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.
Specific Measures Used
This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity.
Definitions
- Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8). We believe that adjusted EBIT provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of unusual, non-operational or restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations because of the excluded items. Adjusted EBIT is one of the measures management uses for planning and budgeting, monitoring and evaluating financial and operating results and as a performance metric in the Company's incentive compensation plan. We may provide guidance on adjusted EBIT but are unable to reconcile forecasted adjusted EBIT to a US GAAP financial measure without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains and losses, which may be significant, is not practical. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales. Adjusted EBIT margin has the same uses and limitations as Adjusted EBIT.
- Adjusted EBIT by core (i.e. Acetyl Chain and/or Materials Solutions) may also be referred to by management as core income. Adjusted EBIT margin by core may also be referred to by management as core income margin. Adjusted EBIT by business segment may also be referred to by management as segment income. Adjusted EBIT margin by business segment may also be referred to by management as segment income margin.
- Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization. We believe that Operating EBITDA provides transparent and useful information to investors, analysts and other parties in evaluating our operating performance relative to our peer companies. Operating EBITDA margin is defined by the Company as Operating EBITDA divided by net sales. Operating EBITDA margin has the same uses and limitations as Operating EBITDA.
- Operating profit (loss) attributable to Celanese Corporation is defined by the Company as operating profit (loss), less earnings (loss) attributable to noncontrolling interests ("NCI"). We believe that operating profit (loss) attributable to Celanese Corporation provides transparent and useful information to management, investors, analysts and other parties in evaluating our core operational performance. Operating margin attributable to Celanese Corporation is defined by the Company as operating profit (loss) attributable to Celanese Corporation divided by net sales. Operating margin attributable to Celanese Corporation has the same uses and limitations as Operating profit (loss) attributable to Celanese Corporation.
-
Adjusted earnings per share is a performance measure used by the
Company and is defined by the Company as earnings (loss) from
continuing operations attributable to Celanese Corporation, adjusted
for income tax (provision) benefit, Certain Items, and refinancing and
related expenses, divided by the number of basic common shares and
dilutive restricted stock units and stock options calculated using the
treasury method. We believe that adjusted earnings per share provides
transparent and useful information to management, investors, analysts
and other parties in evaluating and assessing our primary operating
results from period-to-period after removing the impact of the above
stated items that affect comparability and as a performance metric in
the Company's incentive compensation plan. We may provide guidance on
adjusted earnings per share but are unable to reconcile forecasted
adjusted earnings per share to a GAAP financial measure without
unreasonable efforts because a forecast of Certain Items, such as
mark-to-market pension gains and losses, which may be significant, is
not practical.
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.
- Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our methanol joint venture, Fairway Methanol LLC ("Fairway"). We believe that free cash flow provides useful information to management, investors, analysts and other parties in evaluating the Company's liquidity and credit quality assessment because it provides an indication of the long-term cash generating ability of our business. Although we use free cash flow as a measure to assess the liquidity generated by our business, the use of free cash flow has important limitations, including that free cash flow does not reflect the cash requirements necessary to service our indebtedness, lease obligations, unconditional purchase obligations or pension and postretirement funding obligations.
- Net debt is defined by the Company as total debt less cash and cash equivalents. We believe that net debt provides useful information to management, investors, analysts and other parties in evaluating changes to the Company's capital structure and credit quality assessment.
- Return on invested capital (adjusted) is defined by the Company as adjusted EBIT, tax effected using the adjusted tax rate, divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity. We believe that return on invested capital (adjusted) provides useful information to management, investors, analysts and other parties in order to assess our income generation from the point of view of our stockholders and creditors who provide us with capital in the form of equity and debt and whether capital invested in the Company yields competitive returns. In addition, achievement of certain predetermined targets relating to return on invested capital (adjusted) is one of the factors we consider in determining the amount of performance-based compensation received by our management.
Supplemental Information
Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:
- Net sales for Materials Solutions, the Acetyl Chain and each of our business segments and the percentage increase or decrease in net sales attributable to price, volume, currency and other factors for Materials Solutions, the Acetyl Chain and each of our business segments.
- Cash dividends received from our equity and cost investments.
- For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside stockholders' interests are shown as NCI. Beginning in 2014, this includes Fairway for which the Company's ownership percentage is 50%. Amounts referred to as "attributable to Celanese Corporation" are net of any applicable NCI.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
|
Table 1 - Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited |
||||||||||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | |||||||||||||||||||||||||
| (In $ millions) | ||||||||||||||||||||||||||||||||
| Net earnings (loss) attributable to Celanese Corporation | 226 | 231 | 183 | 900 | 160 | 262 | 221 | 257 | ||||||||||||||||||||||||
| (Earnings) loss from discontinued operations | 4 | 8 | — | 2 | — | 3 | — | (1 | ) | |||||||||||||||||||||||
| Interest income | (1 | ) | (1 | ) | — | (2 | ) | (1 | ) | — | — | (1 | ) | |||||||||||||||||||
| Interest expense | 32 | 30 | 29 | 120 | 29 | 28 | 30 | 33 | ||||||||||||||||||||||||
| Refinancing expense | — | — | — | 6 | — | 4 | — | 2 | ||||||||||||||||||||||||
| Income tax provision (benefit) | 57 | 40 | 56 | 122 | (5 | ) | 15 | 52 | 60 | |||||||||||||||||||||||
|
Certain Items attributable to Celanese Corporation (Table 8) |
27 | 18 | 65 | 130 | 106 | 7 | 9 | 8 | ||||||||||||||||||||||||
| Adjusted EBIT | 345 | 326 | 333 | 1,278 | 289 | 319 | 312 | 358 | ||||||||||||||||||||||||
| Depreciation and amortization expense(1) | 78 | 75 | 71 | 288 | 71 | 71 | 73 | 73 | ||||||||||||||||||||||||
| Operating EBITDA | 423 | 401 | 404 | 1,566 | 360 | 390 | 385 | 431 | ||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | |||||||||||||||||||||||||
| (In $ millions) | ||||||||||||||||||||||||||||||||
| Advanced Engineered Materials | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||
| Consumer Specialties | — | — | — | 1 | — | 1 | — | — | ||||||||||||||||||||||||
| Industrial Specialties | 2 | — | — | — | — | — | — | — | ||||||||||||||||||||||||
| Acetyl Intermediates | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||
| Other Activities(2) | — | — | — | 1 | 1 | — | — | — | ||||||||||||||||||||||||
| Accelerated depreciation and amortization expense | 2 | — | — | 2 | 1 | 1 | — | — | ||||||||||||||||||||||||
| Depreciation and amortization expense(1) | 78 | 75 | 71 | 288 | 71 | 71 | 73 | 73 | ||||||||||||||||||||||||
| Total depreciation and amortization expense | 80 | 75 | 71 | 290 | 72 | 72 | 73 | 73 | ||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
| ______________________________ | ||
|
(1) |
Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above. |
|
|
(2) |
Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
|
|
Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating Profit (Loss) / Operating Margin | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Materials Solutions | 150 | 20.5 | % | 146 | 20.6 | % | 166 | 23.5 | % | 652 | 27.5 | % | 163 | 27.7 | % | 161 | 27.3 | % | 162 | 27.0 | % | 166 | 27.9 | % | ||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain(1) | 148 | 17.1 | % | 135 | 16.3 | % | 52 | 6.5 | % | 446 | 14.2 | % | 86 | 11.5 | % | 108 | 14.2 | % | 107 | 13.7 | % | 145 | 17.3 | % | ||||||||||||||||||||||||||||||||||||||||
| Other Activities(2) | (46 | ) | (41 | ) | (26 | ) | (205 | ) | (132 | ) | (23 | ) | (26 | ) | (24 | ) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 252 | 16.1 | % | 240 | 15.9 | % | 192 | 13.1 | % | 893 | 16.6 | % | 117 | 8.9 | % | 246 | 18.6 | % | 243 | 18.0 | % | 287 | 20.4 | % | ||||||||||||||||||||||||||||||||||||||||
| Less: Net Earnings (Loss) Attributable to NCI(1) | 2 | 2 | 1 | 6 | 1 | 1 | 2 | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating Profit (Loss) Attributable to Celanese Corporation | 250 | 16.0 | % | 238 | 15.8 | % | 191 | 13.0 | % | 887 | 16.5 | % | 116 | 8.8 | % | 245 | 18.5 | % | 241 | 17.8 | % | 285 | 20.3 | % | ||||||||||||||||||||||||||||||||||||||||
| Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Advanced Engineered Materials | 97 | 17.9 | % | 97 | 18.8 | % | 98 | 20.1 | % | 350 | 24.2 | % | 87 | 23.9 | % | 93 | 25.5 | % | 82 | 22.5 | % | 88 | 25.1 | % | ||||||||||||||||||||||||||||||||||||||||
| Consumer Specialties | 53 | 28.3 | % | 49 | 25.4 | % | 68 | 31.2 | % | 302 | 32.5 | % | 76 | 33.8 | % | 68 | 30.2 | % | 80 | 34.0 | % | 78 | 32.0 | % | ||||||||||||||||||||||||||||||||||||||||
| Total Materials Solutions | 150 | 20.5 | % | 146 | 20.6 | % | 166 | 23.5 | % | 652 | 27.5 | % | 163 | 27.7 | % | 161 | 27.3 | % | 162 | 27.0 | % | 166 | 27.9 | % | ||||||||||||||||||||||||||||||||||||||||
| Industrial Specialties | 20 | 7.6 | % | 26 | 9.9 | % | 25 | 10.2 | % | 105 | 10.7 | % | 20 | 9.1 | % | 25 | 10.2 | % | 29 | 11.1 | % | 31 | 12.3 | % | ||||||||||||||||||||||||||||||||||||||||
| Acetyl Intermediates(1) | 126 | 18.4 | % | 107 | 16.5 | % | 26 | 4.2 | % | 334 | 13.7 | % | 65 | 10.9 | % | 82 | 13.9 | % | 75 | 12.7 | % | 112 | 16.9 | % | ||||||||||||||||||||||||||||||||||||||||
| Eliminations | — | — | — | 1 | — | — | 1 | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Acetyl Chain | 146 | 16.9 | % | 133 | 16.1 | % | 51 | 6.4 | % | 440 | 14.0 | % | 85 | 11.3 | % | 107 | 14.0 | % | 105 | 13.5 | % | 143 | 17.0 | % | ||||||||||||||||||||||||||||||||||||||||
| Other Activities(2) | (46 | ) | (41 | ) | (26 | ) | (205 | ) | (132 | ) | (23 | ) | (26 | ) | (24 | ) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 250 | 16.0 | % | 238 | 15.8 | % | 191 | 13.0 | % | 887 | 16.5 | % | 116 | 8.8 | % | 245 | 18.5 | % | 241 | 17.8 | % | 285 | 20.3 | % | ||||||||||||||||||||||||||||||||||||||||
| Equity Earnings, Cost-Dividend Income, Other Income (Expense) Attributable to Celanese Corporation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Advanced Engineered Materials | 45 | 38 | 42 | 122 | 31 | 33 | 27 | 31 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Consumer Specialties | 26 | 28 | 30 | 110 | 27 | 27 | 28 | 28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Materials Solutions | 71 | 66 | 72 | 232 | 58 | 60 | 55 | 59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Industrial Specialties | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Intermediates | 1 | 2 | 1 | 7 | 2 | 1 | 2 | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Acetyl Chain | 1 | 2 | 1 | 7 | 2 | 1 | 2 | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Activities(2) | (4 | ) | 2 | 4 | 22 | 7 | 6 | 5 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 68 | 70 | 77 | 261 | 67 | 67 | 62 | 65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Certain Items Attributable to Celanese Corporation (Table 8) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Advanced Engineered Materials | 5 | 7 | 3 | 7 | 3 | 1 | 2 | 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Consumer Specialties | — | 2 | 2 | 6 | 3 | 3 | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Materials Solutions | 5 | 9 | 5 | 13 | 6 | 4 | 2 | 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Industrial Specialties | 3 | — | — | 1 | (2 | ) | — | 1 | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Intermediates | 7 | (3 | ) | 56 | 6 | 1 | 1 | 3 | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Acetyl Chain | 10 | (3 | ) | 56 | 7 | (1 | ) | 1 | 4 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Activities(2) | 12 | 12 | 4 | 110 | 101 | 2 | 3 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 27 | 18 | 65 | 130 | 106 | 7 | 9 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT / Adjusted EBIT Margin | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Advanced Engineered Materials | 147 | 27.1 | % | 142 | 27.5 | % | 143 | 29.4 | % | 479 | 33.2 | % | 121 | 33.2 | % | 127 | 34.8 | % | 111 | 30.4 | % | 120 | 34.3 | % | ||||||||||||||||||||||||||||||||||||||||
| Consumer Specialties | 79 | 42.2 | % | 79 | 40.9 | % | 100 | 45.9 | % | 418 | 45.0 | % | 106 | 47.1 | % | 98 | 43.6 | % | 108 | 46.0 | % | 106 | 43.4 | % | ||||||||||||||||||||||||||||||||||||||||
| Total Materials Solutions | 226 | 31.0 | % | 221 | 31.2 | % | 243 | 34.5 | % | 897 | 37.8 | % | 227 | 38.5 | % | 225 | 38.1 | % | 219 | 36.5 | % | 226 | 38.0 | % | ||||||||||||||||||||||||||||||||||||||||
| Industrial Specialties | 23 | 8.7 | % | 26 | 9.9 | % | 25 | 10.2 | % | 106 | 10.8 | % | 18 | 8.2 | % | 25 | 10.2 | % | 30 | 11.5 | % | 33 | 13.0 | % | ||||||||||||||||||||||||||||||||||||||||
| Acetyl Intermediates | 134 | 19.6 | % | 106 | 16.3 | % | 83 | 13.4 | % | 347 | 14.2 | % | 68 | 11.4 | % | 84 | 14.3 | % | 80 | 13.5 | % | 115 | 17.3 | % | ||||||||||||||||||||||||||||||||||||||||
| Eliminations | — | — | — | 1 | — | — | 1 | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Acetyl Chain | 157 | 18.2 | % | 132 | 16.0 | % | 108 | 13.6 | % | 454 | 14.5 | % | 86 | 11.5 | % | 109 | 14.3 | % | 111 | 14.2 | % | 148 | 17.6 | % | ||||||||||||||||||||||||||||||||||||||||
| Other Activities(2) | (38 | ) | (27 | ) | (18 | ) | (73 | ) | (24 | ) | (15 | ) | (18 | ) | (16 | ) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 345 | 22.0 | % | 326 | 21.6 | % | 333 | 22.6 | % | 1,278 | 23.7 | % | 289 | 22.0 | % | 319 | 24.1 | % | 312 | 23.1 | % | 358 | 25.5 | % | ||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ___________________________ | ||
|
(1) |
Net earnings (loss) attributable to NCI is included within the Acetyl Intermediates segment. |
|
|
(2) |
Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
|
|
Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.) |
|||||||||||||||||||||||||||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | ||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Depreciation and Amortization Expense(1) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Advanced Engineered Materials | 29 | 26 | 24 | 92 | 21 | 22 | 25 | 24 | |||||||||||||||||||||||||||||||||||||||||
| Consumer Specialties | 11 | 11 | 11 | 44 | 11 | 11 | 11 | 11 | |||||||||||||||||||||||||||||||||||||||||
| Total Materials Solutions | 40 | 37 | 35 | 136 | 32 | 33 | 36 | 35 | |||||||||||||||||||||||||||||||||||||||||
| Industrial Specialties | 8 | 10 | 8 | 34 | 9 | 9 | 8 | 8 | |||||||||||||||||||||||||||||||||||||||||
| Acetyl Intermediates | 26 | 26 | 26 | 107 | 26 | 27 | 27 | 27 | |||||||||||||||||||||||||||||||||||||||||
| Total Acetyl Chain | 34 | 36 | 34 | 141 | 35 | 36 | 35 | 35 | |||||||||||||||||||||||||||||||||||||||||
| Other Activities(2) | 4 | 2 | 2 | 11 | 4 | 2 | 2 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Total | 78 | 75 | 71 | 288 | 71 | 71 | 73 | 73 | |||||||||||||||||||||||||||||||||||||||||
| Operating EBITDA / Operating EBITDA Margin | |||||||||||||||||||||||||||||||||||||||||||||||||
| Advanced Engineered Materials | 176 | 32.4 | % | 168 | 32.6 | % | 167 | 34.3 | % | 571 | 39.5 | % | 142 | 39.0 | % | 149 | 40.8 | % | 136 | 37.3 | % | 144 | 41.1 | % | |||||||||||||||||||||||||
| Consumer Specialties | 90 | 48.1 | % | 90 | 46.6 | % | 111 | 50.9 | % | 462 | 49.7 | % | 117 | 52.0 | % | 109 | 48.4 | % | 119 | 50.6 | % | 117 | 48.0 | % | |||||||||||||||||||||||||
| Total Materials Solutions | 266 | 36.4 | % | 258 | 36.4 | % | 278 | 39.4 | % | 1,033 | 43.5 | % | 259 | 44.0 | % | 258 | 43.7 | % | 255 | 42.5 | % | 261 | 43.9 | % | |||||||||||||||||||||||||
| Industrial Specialties | 31 | 11.7 | % | 36 | 13.7 | % | 33 | 13.5 | % | 140 | 14.3 | % | 27 | 12.3 | % | 34 | 13.9 | % | 38 | 14.5 | % | 41 | 16.2 | % | |||||||||||||||||||||||||
| Acetyl Intermediates | 160 | 23.4 | % | 132 | 20.3 | % | 109 | 17.6 | % | 454 | 18.6 | % | 94 | 15.7 | % | 111 | 18.8 | % | 107 | 18.1 | % | 142 | 21.4 | % | |||||||||||||||||||||||||
| Eliminations | — | — | — | 1 | — | — | 1 | — | |||||||||||||||||||||||||||||||||||||||||
| Total Acetyl Chain | 191 | 22.1 | % | 168 | 20.3 | % | 142 | 17.9 | % | 595 | 19.0 | % | 121 | 16.2 | % | 145 | 19.0 | % | 146 | 18.7 | % | 183 | 21.8 | % | |||||||||||||||||||||||||
| Other Activities(2) | (34 | ) | (25 | ) | (16 | ) | (62 | ) | (20 | ) | (13 | ) | (16 | ) | (13 | ) | |||||||||||||||||||||||||||||||||
| Total | 423 | 27.0 | % | 401 | 26.6 | % | 404 | 27.5 | % | 1,566 | 29.1 | % | 360 | 27.5 | % | 390 | 29.5 | % | 385 | 28.5 | % | 431 | 30.7 | % | |||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| ___________________________ | ||
|
(1) |
Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details. |
|
|
(2) |
Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
|
| Table 3 | |||||||||||||||||||||||||||||||||||||
| Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited | |||||||||||||||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | ||||||||||||||||||||||||||||||
| per | per | per | per | per | per | per | per | ||||||||||||||||||||||||||||||
| share | share | share | share | share | share | share | share | ||||||||||||||||||||||||||||||
| (In $ millions, except per share data) | |||||||||||||||||||||||||||||||||||||
| Earnings (loss) from continuing operations attributable to Celanese Corporation | 230 | 1.68 | 239 | 1.72 | 183 | 1.30 | 902 | 6.19 | 160 | 1.12 | 265 | 1.83 | 221 | 1.50 | 256 | 1.73 | |||||||||||||||||||||
| Income tax provision (benefit) | 57 | 40 | 56 | 122 | (5) | 15 | 52 | 60 | |||||||||||||||||||||||||||||
| Earnings (loss) from continuing operations before tax | 287 | 279 | 239 | 1,024 | 155 | 280 | 273 | 316 | |||||||||||||||||||||||||||||
|
Certain Items attributable to Celanese Corporation (Table 8) |
27 | 18 | 65 | 130 | 106 | 7 | 9 | 8 | |||||||||||||||||||||||||||||
| Refinancing and related expenses | — | — | — | 6 | — | 4 | — | 2 | |||||||||||||||||||||||||||||
| Adjusted earnings (loss) from continuing operations before tax | 314 | 297 | 304 | 1,160 | 261 | 291 | 282 | 326 | |||||||||||||||||||||||||||||
| Income tax (provision) benefit on adjusted earnings(1) | (50) | (48) | (49) | (197) | (44) | (49) | (48) | (55) | |||||||||||||||||||||||||||||
| Adjusted earnings (loss) from continuing operations(2) | 264 | 1.93 | 249 | 1.79 | 255 | 1.81 | 963 | 6.61 | 217 | 1.52 | 242 | 1.67 | 234 | 1.59 | 271 | 1.83 | |||||||||||||||||||||
| Diluted shares (in millions)(3) | |||||||||||||||||||||||||||||||||||||
| Weighted average shares outstanding | 136.6 | 138.6 | 140.6 | 144.9 | 141.9 | 144.0 | 146.5 | 147.4 | |||||||||||||||||||||||||||||
| Incremental shares attributable to equity awards | 0.4 | 0.4 | 0.4 | 0.8 | 0.7 | 0.6 | 0.6 | 0.7 | |||||||||||||||||||||||||||||
| Total diluted shares | 137.0 | 139.0 | 141.0 | 145.7 | 142.6 | 144.6 | 147.1 | 148.1 | |||||||||||||||||||||||||||||
| ______________________________ | |||||||||||||||||||||||||||||||||||||
|
(1) Calculated using adjusted effective tax rates (Table 3a) as follows: |
|||||||||||||||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | ||||||||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||||||||||
| Adjusted effective tax rate | 16 | 16 | 16 | 17 | 17 | 17 | 17 | 17 | |||||||||||||||||||||||||||||
|
(2) Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns. |
|||||||||||||||||||||||||||||||||||||
| Expected | |||||||||||||||||||||||||||||||||||||
| Actual Plan | Plan Asset | ||||||||||||||||||||||||||||||||||||
|
Asset Returns |
Returns | ||||||||||||||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||||||||||
|
2016 |
6.9 | 7.3 | |||||||||||||||||||||||||||||||||||
|
(3) Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive. |
|||||||||||||||||||||||||||||||||||||
| Table 3a | ||||||||
| Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited | ||||||||
| Estimated | Actual | |||||||
| 2017 | 2016 | |||||||
| (In percentages) | ||||||||
| US GAAP effective tax rate | 18 | 12 | ||||||
| Discrete quarterly recognition of GAAP items(1) | (1 | ) | 1 | |||||
| Tax impact of other charges and adjustments(2) | (1 | ) | 3 | |||||
| Utilization of foreign tax credits | — | — | ||||||
| Changes in valuation allowances, excluding impact of other charges and adjustments(3) | — | 2 | ||||||
| Other(4) | — | (1 | ) | |||||
| Adjusted tax rate | 16 | 17 | ||||||
| ______________________________ | ||
|
Note: As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate for actual results. |
||
|
(1) |
Such as changes in tax laws, deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments. |
|
|
(2) |
Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes. |
|
|
(3) |
Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments. |
|
|
(4) |
Tax impacts related to full-year forecasted tax opportunities and related costs. |
|
| Table 4 | |||||||||||||||||||||||||
| Net Sales by Segment - Unaudited | |||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | ||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||
| Advanced Engineered Materials | 543 | 516 | 487 | 1,444 | 364 | 365 | 365 | 350 | |||||||||||||||||
| Consumer Specialties | 187 | 193 | 218 | 929 | 225 | 225 | 235 | 244 | |||||||||||||||||
| Total Materials Solutions | 730 | 709 | 705 | 2,373 | 589 | 590 | 600 | 594 | |||||||||||||||||
| Industrial Specialties | 264 | 262 | 245 | 979 | 219 | 245 | 262 | 253 | |||||||||||||||||
| Acetyl Intermediates | 684 | 649 | 619 | 2,441 | 597 | 589 | 592 | 663 | |||||||||||||||||
| Eliminations(1) | (85 | ) | (85 | ) | (70 | ) | (288 | ) | (67 | ) | (71 | ) | (74 | ) | (76 | ) | |||||||||
| Total Acetyl Chain | 863 | 826 | 794 | 3,132 | 749 | 763 | 780 | 840 | |||||||||||||||||
| Other Activities(2) | — | — | — | — | — | — | — | — | |||||||||||||||||
| Intersegment eliminations(1) | (27 | ) | (25 | ) | (28 | ) | (116 | ) | (27 | ) | (30 | ) | (29 | ) | (30 | ) | |||||||||
| Net sales | 1,566 | 1,510 | 1,471 | 5,389 | 1,311 | 1,323 | 1,351 | 1,404 | |||||||||||||||||
| ___________________________ | |||||||||||||||||||||||||
|
(1) Includes intersegment sales as follows: |
|||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | ||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||
| Industrial Specialties | (1 | ) | (1 | ) | (1 | ) | (3 | ) | (1 | ) | (1 | ) | (1 | ) | — | ||||||||||
| Acetyl Intermediates | (111 | ) | (109 | ) | (97 | ) | (401 | ) | (93 | ) | (100 | ) | (102 | ) | (106 | ) | |||||||||
| Intersegment eliminations | (112 | ) | (110 | ) | (98 | ) | (404 | ) | (94 | ) | (101 | ) | (103 | ) | (106 | ) | |||||||||
|
(2) Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses). |
|||||||||||||||||||||||||
| Table 4a | ||||||||||||||||||
| Factors Affecting Segment Net Sales Sequentially - Unaudited | ||||||||||||||||||
| Three Months Ended September 30, 2017 Compared to Three Months Ended June 30, 2017 | ||||||||||||||||||
| Volume | Price | Currency | Other | Total | ||||||||||||||
| (In percentages) | ||||||||||||||||||
| Advanced Engineered Materials | — | 2 | 3 | — | 5 | |||||||||||||
| Consumer Specialties | (4 | ) | — | 1 | — | (3 | ) | |||||||||||
| Total Materials Solutions | (1 | ) | 1 | 3 | — | 3 | ||||||||||||
| Industrial Specialties | (4 | ) | 2 | 3 | — | 1 | ||||||||||||
| Acetyl Intermediates | 3 | (1 | ) | 3 | — | 5 | ||||||||||||
| Total Acetyl Chain | 1 | — | 3 | — | 4 | |||||||||||||
| Total Company | — | 1 | 3 | — | 4 | |||||||||||||
|
Three Months Ended June 30, 2017 Compared to Three Months Ended March 31, 2017 |
|||||||||||||||||||||
| Volume | Price | Currency | Other | Total | |||||||||||||||||
| (In percentages) | |||||||||||||||||||||
| Advanced Engineered Materials | 4 | — | 2 | — | 6 |
(1) |
|||||||||||||||
| Consumer Specialties | (10 | ) | (2 | ) | — | — | (12 | ) | |||||||||||||
| Total Materials Solutions | — | (1 | ) | 1 | — | — | |||||||||||||||
| Industrial Specialties | 2 | 3 | 2 | — | 7 | ||||||||||||||||
| Acetyl Intermediates | (1 | ) | 5 | 1 | — | 5 | |||||||||||||||
| Total Acetyl Chain | — | 5 | 1 | (2 | ) | 4 | |||||||||||||||
| Total Company | — | 3 | 1 | (1 | ) | 3 | |||||||||||||||
|
Three Months Ended March 31, 2017 Compared to Three Months Ended December 31, 2016 |
|||||||||||||||||||||
| Volume | Price | Currency | Other | Total | |||||||||||||||||
| (In percentages) | |||||||||||||||||||||
| Advanced Engineered Materials | 35 | — | (1 | ) | — | 34 |
(2) |
||||||||||||||
| Consumer Specialties | 3 | (6 | ) | — | — | (3 | ) | ||||||||||||||
| Total Materials Solutions | 22 | (2 | ) | — | — | 20 | |||||||||||||||
| Industrial Specialties | 11 | 1 | — | — | 12 | ||||||||||||||||
| Acetyl Intermediates | (2 | ) | 6 | — | — | 4 | |||||||||||||||
| Total Acetyl Chain | 2 | 5 | (1 | ) | — | 6 | |||||||||||||||
| Total Company | 11 | 2 | (1 | ) | — | 12 | |||||||||||||||
| ___________________________ | ||
|
(1) |
2017 includes the effect of the acquisition of the nylon compounding division of Nilit Group. |
|
|
(2) |
2017 includes the effect of the SO.F.TER. S.p.A. acquisition. |
|
|
Three Months Ended December 31, 2016 Compared to Three Months Ended September 30, 2016 |
|||||||||||||||||||
| Volume | Price | Currency | Other | Total | |||||||||||||||
| (In percentages) | |||||||||||||||||||
| Advanced Engineered Materials | 1 | — | (1 | ) | — | — | |||||||||||||
| Consumer Specialties | 2 | (2 | ) | — | — | — | |||||||||||||
| Total Materials Solutions | 2 | (1 | ) | (1 | ) | — | — | ||||||||||||
| Industrial Specialties | (7 | ) | (2 | ) | (2 | ) | — | (11 | ) | ||||||||||
| Acetyl Intermediates | — | 2 | (1 | ) | — | 1 | |||||||||||||
| Total Acetyl Chain | (2 | ) | 1 | (2 | ) | 1 | (2 | ) | |||||||||||
| Total Company | (1 | ) | 1 | (1 | ) | — | (1 | ) | |||||||||||
|
Three Months Ended September 30, 2016 Compared to Three Months Ended June 30, 2016 |
||||||||||||||||||
| Volume | Price | Currency | Other | Total | ||||||||||||||
| (In percentages) | ||||||||||||||||||
| Advanced Engineered Materials | (1 | ) | 1 | — | — | — | ||||||||||||
| Consumer Specialties | (4 | ) | — | — | — | (4 | ) | |||||||||||
| Total Materials Solutions | (2 | ) | — | — | — | (2 | ) | |||||||||||
| Industrial Specialties | (6 | ) | — | (1 | ) | — | (7 | ) | ||||||||||
| Acetyl Intermediates | — | — | — | — | — | |||||||||||||
| Total Acetyl Chain | (2 | ) | — | (1 | ) | 1 | (2 | ) | ||||||||||
| Total Company | (2 | ) | — | — | — | (2 | ) | |||||||||||
|
Three Months Ended June 30, 2016 Compared to Three Months Ended March 31, 2016 |
||||||||||||||||||
| Volume | Price | Currency | Other | Total | ||||||||||||||
| (In percentages) | ||||||||||||||||||
| Advanced Engineered Materials | 6 | (2 | ) | 1 | — | 5 | ||||||||||||
| Consumer Specialties | (3 | ) | (1 | ) | — | — | (4 | ) | ||||||||||
| Total Materials Solutions | 2 | (2 | ) | 1 | — | 1 | ||||||||||||
| Industrial Specialties | 4 | (1 | ) | 1 | — | 4 | ||||||||||||
| Acetyl Intermediates | (11 | ) | — | — | — | (11 | ) | |||||||||||
| Total Acetyl Chain | (7 | ) | (1 | ) | 1 | — | (7 | ) | ||||||||||
| Total Company | (4 | ) | (1 | ) | 1 | — | (4 | ) | ||||||||||
| Table 4a | ||||||||||||||||||
| Factors Affecting Segment Net Sales Sequentially - Unaudited (cont.) | ||||||||||||||||||
| Three Months Ended March 31, 2016 Compared to Three Months Ended December 31, 2015 | ||||||||||||||||||
| Volume | Price | Currency | Other | Total | ||||||||||||||
| (In percentages) | ||||||||||||||||||
| Advanced Engineered Materials | 12 | — | — | — | 12 | |||||||||||||
| Consumer Specialties | 6 | (7 | ) | — | — | (1 | ) | |||||||||||
| Total Materials Solutions | 10 | (3 | ) | — | — | 7 | ||||||||||||
| Industrial Specialties | 9 | (3 | ) | — | — | 6 | ||||||||||||
| Acetyl Intermediates | 7 | (4 | ) | — | — | 3 | ||||||||||||
| Total Acetyl Chain | 8 | (4 | ) | — | (1 | ) | 3 | |||||||||||
| Total Company | 9 | (4 | ) | — | — | 5 | ||||||||||||
| Table 4b | |||||||||||||||||||
| Factors Affecting Segment Net Sales Year Over Year - Unaudited | |||||||||||||||||||
| Three Months Ended September 30, 2017 Compared to Three Months Ended September 30, 2016 | |||||||||||||||||||
| Volume | Price | Currency | Other | Total | |||||||||||||||
| (In percentages) | |||||||||||||||||||
| Advanced Engineered Materials | 49 | (2 | ) | 2 | — | 49 | |||||||||||||
| Consumer Specialties | (10 | ) | (8 | ) | 1 | — | (17 | ) | |||||||||||
| Total Materials Solutions | 26 | (4 | ) | 2 | — | 24 | |||||||||||||
| Industrial Specialties | 2 | 4 | 2 | — | 8 | ||||||||||||||
| Acetyl Intermediates | (1 | ) | 16 | 1 | — | 16 | |||||||||||||
| Total Acetyl Chain | — | 13 | 2 | (2 | ) | 13 | |||||||||||||
| Total Company | 11 | 6 | 2 | (1 | ) | 18 | |||||||||||||
|
Three Months Ended June 30, 2017 Compared to Three Months Ended June 30, 2016 |
||||||||||||||||||||
| Volume | Price | Currency | Other | Total | ||||||||||||||||
| (In percentages) | ||||||||||||||||||||
| Advanced Engineered Materials | 44 | (2 | ) | (1 | ) | — | 41 | |||||||||||||
| Consumer Specialties | (9 | ) | (9 | ) | — | — | (18 | ) | ||||||||||||
| Total Materials Solutions | 23 | (4 | ) | (1 | ) | — | 18 | |||||||||||||
| Industrial Specialties | (1 | ) | 3 | (2 | ) | — | — | |||||||||||||
| Acetyl Intermediates | (4 | ) | 14 | (1 | ) | 1 | 10 | |||||||||||||
| Total Acetyl Chain | (3 | ) | 12 | (2 | ) | (1 | ) | 6 | ||||||||||||
| Total Company | 8 | 5 | (1 | ) | — | 12 | ||||||||||||||
|
Three Months Ended March 31, 2017 Compared to Three Months Ended March 31, 2016 |
|||||||||||||||||||
| Volume | Price | Currency | Other | Total | |||||||||||||||
| (In percentages) | |||||||||||||||||||
| Advanced Engineered Materials | 44 | (3 | ) | (2 | ) | — | 39 | ||||||||||||
| Consumer Specialties | (2 | ) | (8 | ) | (1 | ) | — | (11 | ) | ||||||||||
| Total Materials Solutions | 25 | (5 | ) | (1 | ) | — | 19 | ||||||||||||
| Industrial Specialties | 1 | (2 | ) | (2 | ) | — | (3 | ) | |||||||||||
| Acetyl Intermediates | (12 | ) | 7 | (2 | ) | — | (7 | ) | |||||||||||
| Total Acetyl Chain | (9 | ) | 5 | (2 | ) | 1 | (5 | ) | |||||||||||
| Total Company | 5 | 1 | (2 | ) | 1 | 5 | |||||||||||||
|
Three Months Ended December 31, 2016 Compared to Three Months Ended December 31, 2015 |
|||||||||||||||
| Volume | Price | Currency | Other | Total | |||||||||||
| (In percentages) | |||||||||||||||
| Advanced Engineered Materials | 20 | (2) | (1) | — | 17 | ||||||||||
| Consumer Specialties | 2 | (11) | — | — | (9) | ||||||||||
| Total Materials Solutions | 12 | (6) | — | — | 6 | ||||||||||
| Industrial Specialties | (1) | (6) | (1) | — | (8) | ||||||||||
| Acetyl Intermediates | (4) | (2) | (2) | 1 | (7) | ||||||||||
| Total Acetyl Chain | (4) | (3) | (2) | 1 | (8) | ||||||||||
| Total Company | 2 | (4) | (1) | 1 | (2) | ||||||||||
|
Three Months Ended September 30, 2016 Compared to Three Months Ended September 30, 2015 |
|||||||||||||||||||
| Volume | Price | Currency | Other | Total | |||||||||||||||
| (In percentages) | |||||||||||||||||||
| Advanced Engineered Materials | 16 | (4 | ) | — | — | 12 | |||||||||||||
| Consumer Specialties | (2 | ) | (7 | ) | — | — | (9 | ) | |||||||||||
| Total Materials Solutions | 8 | (5 | ) | — | — | 3 | |||||||||||||
| Industrial Specialties | (1 | ) | (9 | ) | (1 | ) | — | (11 | ) | ||||||||||
| Acetyl Intermediates | (3 | ) | (11 | ) | — | 1 | (13 | ) | |||||||||||
| Total Acetyl Chain | (3 | ) | (12 | ) | — | 2 | (13 | ) | |||||||||||
| Total Company | 1 | (9 | ) | — | 2 | (6 | ) | ||||||||||||
|
Three Months Ended June 30, 2016 Compared to Three Months Ended June 30, 2015 |
||||||||||||||||||
| Volume | Price | Currency | Other | Total | ||||||||||||||
| (In percentages) | ||||||||||||||||||
| Advanced Engineered Materials | 8 | (4 | ) | 1 | — | 5 | ||||||||||||
| Consumer Specialties | 2 | (8 | ) | — | — | (6 | ) | |||||||||||
| Total Materials Solutions | 5 | (5 | ) | 1 | — | 1 | ||||||||||||
| Industrial Specialties | (1 | ) | (8 | ) | — | — | (9 | ) | ||||||||||
| Acetyl Intermediates | (5 | ) | (13 | ) | — | 2 | (16 | ) | ||||||||||
| Total Acetyl Chain | (4 | ) | (12 | ) | — | 2 | (14 | ) | ||||||||||
| Total Company | — | (10 | ) | — | 1 | (9 | ) | |||||||||||
| Table 4b | |||||||||||||||
| Factors Affecting Segment Net Sales Year Over Year - Unaudited (cont.) | |||||||||||||||
| Three Months Ended March 31, 2016 Compared to Three Months Ended March 31, 2015 | |||||||||||||||
| Volume | Price | Currency | Other | Total | |||||||||||
| (In percentages) | |||||||||||||||
| Advanced Engineered Materials | 5 | (2) | (1) | — | 2 | ||||||||||
| Consumer Specialties | 17 | (9) | — | — | 8 | ||||||||||
| Total Materials Solutions | 9 | (5) | — | — | 4 | ||||||||||
| Industrial Specialties | — | (9) | (1) | — | (10) | ||||||||||
| Acetyl Intermediates | 6 | (13) | (2) | 2 | (7) | ||||||||||
| Total Acetyl Chain | 5 | (13) | (2) | 1 | (9) | ||||||||||
| Total Company | 7 | (10) | (2) | 1 | (4) | ||||||||||
| Table 4c | |||||||||||||||||||
| Factors Affecting Segment Net Sales Year Over Year - Unaudited | |||||||||||||||||||
| Year Ended December 31, 2016 Compared to Year Ended December 31, 2015 | |||||||||||||||||||
| Volume | Price | Currency | Other | Total | |||||||||||||||
| (In percentages) | |||||||||||||||||||
| Advanced Engineered Materials | 11 | (2 | ) | — | — | 9 | |||||||||||||
| Consumer Specialties | 4 | (8 | ) | — | — | (4 | ) | ||||||||||||
| Total Materials Solutions | 8 | (5 | ) | — | — | 3 | |||||||||||||
| Industrial Specialties | (1 | ) | (8 | ) | (1 | ) | — | (10 | ) | ||||||||||
| Acetyl Intermediates | (2 | ) | (10 | ) | (1 | ) | 2 | (11 | ) | ||||||||||
| Total Acetyl Chain | (2 | ) | (10 | ) | (1 | ) | 2 | (11 | ) | ||||||||||
| Total Company | 2 | (8 | ) | (1 | ) | 2 | (5 | ) | |||||||||||
| Table 5 | ||||||||||||||||||||||||||||||||
| Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited | ||||||||||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | |||||||||||||||||||||||||
| (In $ millions) | ||||||||||||||||||||||||||||||||
| Net cash provided by (used in) investing activities | (68 | ) | (325 | ) | (64 | ) | (439 | ) | (247 | ) | (54 | ) | (63 | ) | (75 | ) | ||||||||||||||||
| Net cash provided by (used in) financing activities | (247 | ) | 21 | (270 | ) | (759 | ) | (292 | ) | 265 | (259 | ) | (473 | ) | ||||||||||||||||||
| Net cash provided by (used in) operating activities | 255 | 298 | 192 | 893 | (47 | ) | 304 | 349 | 287 | |||||||||||||||||||||||
| Capital expenditures on property, plant and equipment | (64 | ) | (54 | ) | (62 | ) | (246 | ) | (60 | ) | (58 | ) | (58 | ) | (70 | ) | ||||||||||||||||
| Capital (distributions to) contributions from NCI | (10 | ) | (4 | ) | (4 | ) | (24 | ) | (9 | ) | (9 | ) | (6 | ) | — | |||||||||||||||||
| Free cash flow(1)(2) | 181 | 240 | 126 | 623 | (116 | ) | 237 | 285 | 217 | |||||||||||||||||||||||
| ______________________________ | ||
|
(1) |
Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our joint venture, Fairway Methanol LLC ("Fairway"). |
|
|
(2) |
Excludes required debt service and capital lease payments of $27 million and $56 million for the years ending December 31, 2017 and 2016, respectively. |
|
| Table 6 | ||||||||||||||||||||||||
| Cash Dividends Received - Unaudited | ||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | |||||||||||||||||
| (In $ millions) | ||||||||||||||||||||||||
| Dividends from equity method investments | 5 | 59 | 50 | 131 | 15 | 6 | 73 | 37 | ||||||||||||||||
| Dividends from cost method investments | 24 | 29 | 29 | 108 | 26 | 26 | 29 | 27 | ||||||||||||||||
| Total | 29 | 88 | 79 | 239 | 41 | 32 | 102 | 64 | ||||||||||||||||
| Table 7 | ||||||||||||||||||||||||||||||||
| Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited | ||||||||||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | |||||||||||||||||||||||||
| (In $ millions) | ||||||||||||||||||||||||||||||||
| Short-term borrowings and current installments of long-term debt - third party and affiliates | 435 | 384 | 107 | 118 | 118 | 92 | 119 | 116 | ||||||||||||||||||||||||
| Long-term debt, net of unamortized deferred financing costs | 2,954 | 2,931 | 2,851 | 2,890 | 2,890 | 2,923 | 2,464 | 2,487 | ||||||||||||||||||||||||
| Total debt | 3,389 | 3,315 | 2,958 | 3,008 | 3,008 | 3,015 | 2,583 | 2,603 | ||||||||||||||||||||||||
| Cash and cash equivalents | (461 | ) | (511 | ) | (501 | ) | (638 | ) | (638 | ) | (1,252 | ) | (735 | ) | (716 | ) | ||||||||||||||||
| Net debt | 2,928 | 2,804 | 2,457 | 2,370 | 2,370 | 1,763 | 1,848 | 1,887 | ||||||||||||||||||||||||
| Table 8 | ||||||||||||||||||||||||||||||||
| Certain Items - Unaudited | ||||||||||||||||||||||||||||||||
|
The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures: |
||||||||||||||||||||||||||||||||
| Q3 '17 | Q2 '17 | Q1 '17 | 2016 | Q4 '16 | Q3 '16 | Q2 '16 | Q1 '16 | Income Statement Classification | ||||||||||||||||||||||||
| (In $ millions) | ||||||||||||||||||||||||||||||||
| Employee termination benefits(1) | — | 2 | 2 | 11 | — | 3 | 3 | 5 | Other charges (gains), net | |||||||||||||||||||||||
| Plant/office closures | 2 | (3 | ) | 57 | 4 | 1 | 2 | — | 1 | Cost of sales / SG&A / R&D / Other charges (gains), net | ||||||||||||||||||||||
| Business optimization | 4 | — | — | 7 | 3 | 1 | 1 | 2 | Cost of sales / SG&A | |||||||||||||||||||||||
| Asset impairments | — | — | — | 2 | 1 | — | 1 | — | Other charges (gains), net | |||||||||||||||||||||||
| (Gain) loss on disposition of business and assets, net | — | 2 | — | (4 | ) | (2 | ) | (2 | ) | — | — | (Gain) loss on disposition, net | ||||||||||||||||||||
| Commercial disputes | — | — | — | (2 | ) | (2 | ) | — | — | — | Other charges (gains), net | |||||||||||||||||||||
| Write-off of other productive assets | — | — | — | 4 | 1 | 1 | 2 | — | Cost of sales / R&D | |||||||||||||||||||||||
| Employee benefit plan changes | — | 1 | — | 1 | — | — | 1 | — | Cost of sales / SG&A / R&D | |||||||||||||||||||||||
| Actuarial (gain) loss on pension and postretirement plans | — | — | — | 102 | 102 | — | — | — | Cost of sales / SG&A / R&D | |||||||||||||||||||||||
| Start-up costs | — | — | — | 2 | — | 1 | 1 | — | Cost of sales | |||||||||||||||||||||||
| Mergers and acquisitions | 10 | 7 | 9 | 3 | 2 | 1 | — | — | Cost of sales / SG&A | |||||||||||||||||||||||
| InfraServ ownership change | — | 8 | — | — | — | — | — | — | Other charges (gains), net / Equity in net earnings (loss) of affiliates | |||||||||||||||||||||||
| Impact from natural disasters(2) | 11 | — |
|
— | — | — | — | — | — | Cost of sales | ||||||||||||||||||||||
| Other | — | 1 | (3 | ) | — | — | — | — | — | Equity in net earnings (loss) of affiliates | ||||||||||||||||||||||
| Certain Items attributable to Celanese Corporation | 27 | 18 | 65 | 130 | 106 | 7 | 9 | 8 | ||||||||||||||||||||||||
| ______________________________ | ||
|
(1) |
Primarily associated with site shutdown costs. |
|
|
(2) |
Primarily associated with Hurricane Harvey. |
|
| Table 9 | ||||||||||
| Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited | ||||||||||
| 2016 | ||||||||||
| (In $ millions, | ||||||||||
| except percentages) | ||||||||||
| Net earnings (loss) attributable to Celanese Corporation | 900 | |||||||||
|
Adjusted EBIT (Table 1)
|
1,278 | |||||||||
| Adjusted effective tax rate (Table 3a) | 17 | % | ||||||||
| Adjusted EBIT tax effected | 1,061 | |||||||||
| 2016 | 2015 | Average | ||||||||
| (In $ millions, except percentages) | ||||||||||
| Short-term borrowings and current installments of long-term debt - third parties and affiliates | 118 | 513 | 316 | |||||||
| Long-term debt, net of unamortized deferred financing costs | 2,890 | 2,468 | 2,679 | |||||||
| Celanese Corporation stockholders' equity | 2,588 | 2,378 | 2,483 | |||||||
| Invested capital | 5,478 | |||||||||
| Return on invested capital (adjusted) | 19.4 | % | ||||||||
| Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital | 16.4 | % | ||||||||
